Welcome to our dedicated page for SMED news (Ticker: SMED), a resource for investors and traders seeking the latest updates and insights on SMED stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SMED's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SMED's position in the market.
Sharps Compliance Corp. (SMED) reported strong financial results for Q4 and full-year fiscal 2021. Q4 revenue reached $18.7 million, a 49% increase YoY, while full-year revenue was $76.4 million (+49% YoY). Net income in Q4 was $5.1 million ($0.29 per share), with operating income of $2.0 million. Customer billings surged by 38% in Q4, driven by immunization-related orders. The company closed the year with a strong cash balance of $27.8 million and improved gross margins of 38%.
Sharps Compliance Corp. (NASDAQ: SMED) will announce its fourth quarter 2021 results on August 18, 2021, prior to market opening. The announcement will be followed by a conference call at 11:00 a.m. ET where management will discuss the financial results and future business strategies. Domestic callers can join by dialing (877) 407-0782, while international participants can call (201) 689-8567. The call will also be available via webcast. A replay of the call will be accessible until September 17, 2021.
Sharps Compliance Corp. (NASDAQ: SMED) will have David P. Tusa, President and CEO, participating in the ROTH Virtual London Conference on June 22, 2021. Tusa will engage in one-on-one meetings throughout the event, showcasing the company’s business-to-business services in healthcare, long-term care, and retail pharmacy markets. Sharps Compliance specializes in managing regulated medical waste, hazardous waste, and unused medications. For more details, visit www.sharpsinc.com.
Sharps Compliance Corp. (Nasdaq: SMED) announced that CEO David P. Tusa will present at the Stifel 2021 Virtual Cross Sector Insight Conference on June 10, 2021, at 9:20 a.m. ET. Additionally, he will hold one-on-one meetings throughout the day. The presentation is available online for interested stakeholders.
Sharps Compliance specializes in services for regulated medical waste, hazardous waste, and unused medications management, primarily serving healthcare and pharmacy markets.
Sharps Compliance Corp. (NASDAQ: SMED) announced the resignation of Jack Holmes from its Board of Directors effective May 21, 2021, to focus on other business commitments. Holmes had previously declined to stand for re-election at the Company's Annual Meeting in November 2021. The decision wasn't a result of disagreements with the Company's operations or policies. Sharon R. Gabrielson, Chair of the Board, expressed gratitude for Holmes' contributions.
Sharps Compliance specializes in waste management solutions for medical, pharmaceutical, and hazardous waste.
Sharps Compliance Corp. (NASDAQ: SMED) reported impressive financial results for Q3 fiscal 2021. Revenue surged 164% year-over-year to $27.5 million, driven by a 200% increase in customer billings, reaching $31.0 million. Notably, retail market billings skyrocketed by 838%, attributed to robust COVID-19 related orders, while net income stood at $6.9 million, translating to $0.40 per share. Gross margins improved from 21% to 49%. The company remains optimistic about sustained demand for its services, particularly in the COVID-19 vaccination context, and is expanding its route-based services across the U.S.
Sharps Compliance Corp. (NASDAQ: SMED) will release its third quarter 2021 financial results on April 28, 2021, before market opening. The company will discuss these results and key initiatives during a conference call at 11:00 a.m. ET. Investors can access the call via phone or webcast. The company provides comprehensive solutions for managing regulated medical waste and unused medications, serving healthcare and retail markets. A telephonic replay will be available until May 28, 2021, and a transcript will be posted afterward.
Sharps Compliance Corp. (NASDAQ: SMED) announced that its CEO, David P. Tusa, will participate in a fireside chat and hold one-on-one meetings during Gabelli & Company’s 7th Annual Waste & Environmental Services Symposium on March 18, 2021. This event will be held virtually, highlighting Sharps Compliance's leadership in providing solutions for managing regulated medical waste and hazardous materials in the healthcare sector.
Sharps Compliance Corp. (NASDAQ: SMED) announces CEO David P. Tusa will participate in the ROTH Virtual Conference on March 16, 2021. He will be available for one-on-one and small group meetings from 9:00 a.m. to 6:00 p.m. ET via teleconference.
Sharps Compliance, based in Houston, Texas, provides business-to-business services for the healthcare sector, focusing on the management of regulated medical waste, hazardous waste, and unused medications. For more details, visit www.sharpsinc.com.
Sharps Compliance Corp. (NASDAQ: SMED) has expanded its direct route-based services to include Arizona, Colorado, New Mexico, and Utah, enhancing its geographic coverage to 37 states, serving 80% of the U.S. population. The company reported a 41% year-over-year revenue increase from its route-based services, with customer locations rising to 14,910. Demand for COVID-19-related mailback orders remains strong, and the company has tripled its treatment capacity to meet ongoing needs. This strategic expansion positions Sharps to capitalize on market growth amid increasing healthcare demands.
FAQ
What is the market cap of SMED (SMED)?
